Tome Biosciences (Group)

https://www.tome.bio

Tome Biosciences, Inc., is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome with site-specific precision. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and integrative gene therapies. *

	Start	2023-12-12 start announced
	Industry	programmable genomic integration technology (PGI technology)

	Region	Watertown, MA
	Country	United States (USA)
	Street	100 Talcott Avenue
	City	02472 Watertown, MA
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Tome Biosciences, Inc.. (12/12/23). "Press Release: Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform". Watertown, MA.

		Record changed: 2025-02-16

Picture Consultech GmbH New EU Grants v2 650x200px

More documents for Tome Biosciences (Group)

[1] Tome Biosciences, Inc.. (12/12/23). "Press Release: Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform". Watertown, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com